Interv Akut Kardiol. 2018;17(3):144-147 | DOI: 10.36290/kar.2018.013

Incidence and prognosis of patients with arrhythmogenic right ventricular dysplasia

David Šipula1, Milan Kozák2, Jiří Plášek1, Miroslav Homza1
1 Kardiovaskulární oddělení, Fakultní nemocnice Ostrava
2 Interní kardiologická klinika, Fakultní nemocnice Brno Bohunice

Objective: To monitor the proportion of patients with the diagnosis of arrhythmogenic right ventricular dysplasia (ARVD) indicatedfor ICD implantation.

Method: The authors describe the incidence of ARVD in a population during a six-year period and monitor the clinical manifestationsin patients with this diagnosis as well as the examination methods and, subsequently, the rate of arrhythmias.

Results: Our cohort comprised 6 patients with ARVD, with all of them having symptoms indicative of a haemodynamically significantventricular arrhythmia manifested by syncopal or presyncopal states. As evidenced by echocardiography, all the patientshad right ventricular dilation, which was confirmed by x-ray changes in 5 patients. These patients were indicated for implantablecardioverter defibrillator (ICD) placement according to the guidelines. During follow-up, haemodynamically significant ventriculararrhythmias were detected in 4 patients, of whom 3 patients were indicated for radiofrequency catheter ablation of a substratefrom the right ventricle due to recurrent ventricular arrhythmia.

Conclusion: Although a rare condition, the diagnosis of ARVD must be considered in patients with a history of syncope, presyncopalstates, or palpitations, particularly with exertion at a young age. In these patients, at least, radiographic and echocardiographicevaluation should be performed.

Keywords: arrhythmogenic right ventricular dysplasia, syncope, ICD implantation

Received: July 16, 2018; Accepted: July 16, 2018; Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šipula D, Kozák M, Plášek J, Homza M. Incidence and prognosis of patients with arrhythmogenic right ventricular dysplasia. Interv Akut Kardiol. 2018;17(3):144-147. doi: 10.36290/kar.2018.013.
Download citation

References

  1. Basso C, Corrado D, Thiene G. Cardiovascular causes of sudden death in young individuals including athletes. Cardiol Rev 1999; 7: 127-135. Go to original source... Go to PubMed...
  2. Tabib A, Loire R, Chalabreysse L, et al. Circumstances of death and gross and microscopic observations in a series of 200 cases of sudden death associated with arrhythmogenic right ventricular cardiomyopathy and/or dysplasia. Circulation 2003; 108: 3000-3005. Go to original source... Go to PubMed...
  3. Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol 2013; 6: 562-568. Go to original source... Go to PubMed...
  4. Nasir K, Bomba C, Tandri H, et al. Electrocardiographic features of arrhythmogenic right ventricular dysplasia/cardiomyopathy according to disease severity: a need to broaden diagnostic criteria. Circulation 2004; 110(12): 1527-1534. Go to original source... Go to PubMed...
  5. Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Circulation 2010; 121(13): 1533-1541. Go to original source... Go to PubMed...
  6. Basso C, Thiene G. Adipositas cordis, fatty infiltration of the right ventricle, and arrhythmogenic right ventricular cardiomyopathy. Just a matter of fat? Cardiovasc Pathol 2005; 14(1): 37-41. Go to original source... Go to PubMed...
  7. Leclerq JF, Potenza S, Mason-Blanche P, Chastang C, Coumel P. Determinants of spontaneous occurrence of sustained monomorphic ventricular tachycardia in right ventricular dysplasia. J Am Coll Cardiol 1996; 28(3): 720-724. Go to original source...
  8. Marcus GM, Glidden DV, Polonsky B. Multidisciplinary Study of Right Ventricular Dysplasia Investigators. Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: a report from the North American ARVC Registry. J Am Coll Cardiol 2009; 54: 609-615. Go to original source... Go to PubMed...
  9. Schinkel AF. Implantable cardioverter defibrillators in arrhythmogenic right ventricular dysplasia/cardiomyopathy: patient outcomes, incidence of appropriate and inappropriate interventions, and complications. Circ Arrhythm Electrophysiol 2013; 6: 562-568. Go to original source... Go to PubMed...
  10. Haman L. Arytmogenní kardiomyopatie pravé komory, Interv Akut Kardiol 2014; 13(2): 87-91.
  11. ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac dech, European Heart Journal 2015; 36: 2832.




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.